公开(公告)号：US20240130959A1

公开(公告)日：2024-04-25

申请号：US17769493

申请日：2020-09-23

申请人： Maria TRIPOD

发明人： Maria TRIPOD

IPC分类号： A61K8/9771 ,  A61K8/19 ,  A61K8/34 ,  A61K8/49 ,  A61K8/60 ,  A61K8/67 ,  A61K8/73 ,  A61K8/9789 ,  A61K31/047 ,  A61K31/351 ,  A61K31/375 ,  A61K31/4174 ,  A61K31/455 ,  A61K31/7034 ,  A61K31/728 ,  A61K33/10 ,  A61K36/16 ,  A61K36/258 ,  A61K36/87 ,  A61Q19/02

CPC分类号： A61K8/9771 ,  A61K8/19 ,  A61K8/345 ,  A61K8/4946 ,  A61K8/498 ,  A61K8/602 ,  A61K8/675 ,  A61K8/676 ,  A61K8/735 ,  A61K8/9789 ,  A61K31/047 ,  A61K31/351 ,  A61K31/375 ,  A61K31/4174 ,  A61K31/455 ,  A61K31/7034 ,  A61K31/728 ,  A61K33/10 ,  A61K36/16 ,  A61K36/258 ,  A61K36/87 ,  A61Q19/02

摘要： The product is made of phytotherapeutic active substances extracted from roots, stems and leaves of medicinal plants, biological emulsifier, synthetic active substances of organic origin in small quantities, minerals and water. The product is made in the oil, water and dry phases according to best manufacturing practice to obtain a high-quality cream to treat acne and melasma safely, quickly and effectively. The cream can be used to treat all skin types, is applied to the affected area, and has anti-inflammatory, antiseptic, antioxidant, healing, anti-fungicidal, moisturizing and skin-lightening properties.

公开(公告)号：US20240074481A1

公开(公告)日：2024-03-07

申请号：US18389152

申请日：2023-11-13

申请人： R.J. REYNOLDS TOBACCO COMPANY

发明人： Paul Stuart Chapman ,  David Troy Turfler

IPC分类号： A24B13/00 ,  A24B15/16 ,  A24B15/24 ,  A24B15/28 ,  A24B15/30 ,  A24B15/40 ,  A24B15/42 ,  A61K9/00 ,  A61K31/05 ,  A61K31/122 ,  A61K31/125 ,  A61K31/191 ,  A61K31/194 ,  A61K31/198 ,  A61K31/20 ,  A61K31/352 ,  A61K31/375 ,  A61K31/4015 ,  A61K31/465 ,  A61K31/522 ,  A61K31/7004 ,  A61K36/07 ,  A61K36/16 ,  A61K36/28 ,  A61K36/38 ,  A61K36/45 ,  A61K36/67 ,  A61K36/752 ,  A61K36/82 ,  A61K36/889 ,  A61K36/8962 ,  A61K36/9068 ,  A61K47/38

CPC分类号： A24B13/00 ,  A24B15/16 ,  A24B15/241 ,  A24B15/282 ,  A24B15/283 ,  A24B15/303 ,  A24B15/403 ,  A24B15/42 ,  A61K9/009 ,  A61K31/05 ,  A61K31/122 ,  A61K31/125 ,  A61K31/191 ,  A61K31/194 ,  A61K31/198 ,  A61K31/20 ,  A61K31/352 ,  A61K31/375 ,  A61K31/4015 ,  A61K31/465 ,  A61K31/522 ,  A61K31/7004 ,  A61K36/07 ,  A61K36/16 ,  A61K36/28 ,  A61K36/38 ,  A61K36/45 ,  A61K36/67 ,  A61K36/752 ,  A61K36/82 ,  A61K36/889 ,  A61K36/8962 ,  A61K36/9068 ,  A61K47/38 ,  A61K2236/331 ,  A61K2236/333

摘要： A pouched product adapted for release of a releasable component therefrom is provided herein. The pouched product can include a water-permeable fabric pouch formed so as to define a cavity therein, and a composition contained within the cavity of the water-permeable fabric pouch, the composition including one or more releasable components that are released from the composition under mouth conditions and that are capable of movement through the water-permeable fabric pouch. The composition includes nicotine and at least one particulate non-tobacco material. The pouched product also includes at least one capsule contained within the cavity of the water-permeable fabric pouch, the capsule having a capsule wall surrounding an inner payload comprising at least one botanical.

公开(公告)号：US20240024396A1

公开(公告)日：2024-01-25

申请号：US18024944

申请日：2021-09-24

申请人： CJ CHEILJEDANG CORPORATION

发明人： Kyuyeol Son ,  Min Ah Park ,  Kyung Min Lee ,  Hwi-Jea Kim

IPC分类号： A61K36/16 ,  A61K31/365 ,  A61K31/353 ,  A61P33/02

CPC分类号： A61K36/16 ,  A61K31/365 ,  A61K31/353 ,  A61P33/02 ,  A61K2236/333

摘要： The present application relates to an anticoccidial composition comprising ginkgo leaves and use thereof. The composition comprising ginkgo leaves, according to an embodiment, has excellent effects of directly killing sporozoites that can induce coccidiosis, inhibiting the penetration of the sporozoites into cells, and/or inhibiting the proliferation of the sporozoites in cells, and has excellent effects of preventing, ameliorating and treating coccidiosis in vivo.

公开(公告)号：US10039730B2

公开(公告)日：2018-08-07

申请号：US15409655

申请日：2017-01-19

申请人： Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center

发明人： Guochuan Emil Tsai

IPC分类号： A01N59/00 ,  A61K33/00 ,  A61K31/192 ,  A61K31/5513

CPC分类号： A61K31/47 ,  A61K31/11 ,  A61K31/12 ,  A61K31/13 ,  A61K31/16 ,  A61K31/167 ,  A61K31/19 ,  A61K31/192 ,  A61K31/196 ,  A61K31/22 ,  A61K31/235 ,  A61K31/245 ,  A61K31/27 ,  A61K31/35 ,  A61K31/382 ,  A61K31/438 ,  A61K31/445 ,  A61K31/5513 ,  A61K33/00 ,  A61K36/16 ,  A61K45/06 ,  A61P25/00 ,  A61K2300/00

摘要： Methods and compositions are provided for treating neuropsychiatric disorders such as schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, and bipolar disorder. The methods entail administering to a patient diagnosed as having a neuropsychiatric disorder (e.g., schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia bipolar disorder, etc.) or as at risk for a neuropsychiatric disorder a benzoic acid, benzoic acid salt, and/or benzoic acid derivative, and/or a sorbic acid, sorbic acid salt, and/or sorbic acid derivative, in combination with a neuropharmacological agent (e.g., an antipsychotic, an antidepressant, medications for attention deficit and hyperactivity disorder, cognitive impairment, or dementia, etc.) where the benzoic acid, benzoic acid salt, or benzoic acid derivative, and/or a sorbic acid, sorbic acid salt, and/or sorbic acid derivative, is in an amount sufficient to increase the efficacy of the neuropharmacological agent.

公开(公告)号：US20170367350A1

公开(公告)日：2017-12-28

申请号：US15521468

申请日：2014-10-31

申请人： KIMBERLY-CLARK WORLDWIDE, INC.

发明人： David W. Koenig ,  Kathleen C. Engelbrecht ,  Amy L. Vanden Heuvel ,  Vinod Chaudhary ,  Scott W. Wenzel ,  Divesh Bhatt ,  Yang Huang ,  Aimin He

IPC分类号： A01N65/00 ,  A01N65/30 ,  A01N65/24 ,  A01N65/08 ,  A01N25/08 ,  A01N45/00 ,  A01N43/32 ,  A01N31/16 ,  A01N65/40 ,  A01N65/20

CPC分类号： A01N65/00 ,  A01N25/08 ,  A01N31/16 ,  A01N43/32 ,  A01N45/00 ,  A01N65/08 ,  A01N65/20 ,  A01N65/24 ,  A01N65/30 ,  A01N65/40 ,  A61K8/0208 ,  A61K8/347 ,  A61K8/498 ,  A61K8/97 ,  A61K36/16 ,  A61K36/48 ,  A61K36/481 ,  A61K36/482 ,  A61K36/708 ,  A61K36/77 ,  A61K36/8962 ,  A61Q17/00

摘要： A composition for inhibiting the attachment of microbes to an animate or inanimate surface is disclosed. The composition includes a carrier and an effective amount of an anti-adherent agent. The anti-adherent agents include botanical agents such Soybean extract, Horse chestnut extract, Gypenoside, Resveratrol, Astragalus extract, Rhubarb rootextract, Allium cepaextract, Cassia seedextract, Ginkgo bilobaextract, and Silymarin, and combinations thereof. The efficacy of the botanical agents is microbe and surface dependent. Various delivery vehicles, including a wipe, may be used to deliver the composition to the surface.

公开(公告)号：US20170360733A1

公开(公告)日：2017-12-21

申请号：US15534319

申请日：2015-12-01

申请人： NIHON SIZEN HAKKOH CO., LTD.

发明人： Naoki HIGASHI ,  Masahiro NAKANISHI

IPC分类号： A61K31/198 ,  A23K50/50 ,  A61K36/8998 ,  A61K36/8994 ,  A61K36/899 ,  A61K36/8967 ,  A61K36/8962 ,  A61K36/8945 ,  A61K36/888 ,  A61K36/88 ,  A61K36/87 ,  A61K36/81 ,  A61K36/78 ,  A61K36/752 ,  A61K36/736 ,  A61K36/73 ,  A61K36/605 ,  A61K36/60 ,  A61K36/535 ,  A61K36/52 ,  A61K36/49 ,  A61K36/48 ,  A61K36/44 ,  A61K36/42 ,  A61K36/31 ,  A61K36/282 ,  A61K36/28 ,  A61K36/23 ,  A61K36/185 ,  A61K36/16 ,  A61K36/07 ,  A61K36/03 ,  A61K31/4172 ,  A61K31/405 ,  A61K31/401 ,  A61K31/352 ,  A61K31/194 ,  A61K31/192 ,  A61K31/19 ,  A61K8/99 ,  A61K36/9066 ,  A23L2/52 ,  A23L33/105 ,  A23K10/12 ,  A61K36/9068

CPC分类号： A61K31/198 ,  A23K10/12 ,  A23K50/50 ,  A23L2/52 ,  A23L33/105 ,  A23V2002/00 ,  A61K8/99 ,  A61K31/19 ,  A61K31/192 ,  A61K31/194 ,  A61K31/196 ,  A61K31/197 ,  A61K31/352 ,  A61K31/353 ,  A61K31/401 ,  A61K31/405 ,  A61K31/4172 ,  A61K35/744 ,  A61K36/03 ,  A61K36/062 ,  A61K36/064 ,  A61K36/07 ,  A61K36/16 ,  A61K36/185 ,  A61K36/23 ,  A61K36/28 ,  A61K36/282 ,  A61K36/31 ,  A61K36/39 ,  A61K36/42 ,  A61K36/44 ,  A61K36/48 ,  A61K36/49 ,  A61K36/52 ,  A61K36/535 ,  A61K36/60 ,  A61K36/605 ,  A61K36/73 ,  A61K36/736 ,  A61K36/75 ,  A61K36/752 ,  A61K36/78 ,  A61K36/81 ,  A61K36/87 ,  A61K36/88 ,  A61K36/888 ,  A61K36/8945 ,  A61K36/8962 ,  A61K36/8967 ,  A61K36/899 ,  A61K36/8994 ,  A61K36/8998 ,  A61K36/9066 ,  A61K36/9068

摘要： An object of the present invention is to provide a senescence retarding agent that delays the onset of senescence symptoms and extends longevity, and is superior in safety. The senescence retarding agent of the present invention that achieves the object is characterized by containing a plant fermentation product as an active ingredient, the plant fermentation product being a mixture of the following: (a) a koji mold-fermented product of one or more kinds of beans and/or cereals selected from the group consisting of barley, black soybean, red rice, black rice, adzuki bean, adlay, Japanese millet, foxtail millet, and millet; (b) a yeast- and/or lactic acid bacterium-fermented product of one or more kinds of fruits selected from the group consisting of mikan (mandarin orange), grape, apple, yama-budo (crimson glory grape), peach, kaki (Japanese persimmon), papaya, nashi (Japanese pear), watermelon, ume (Japanese apricot), fig, karin (Chinese quince), pumpkin, kumquat, yuzu (Chinese lemon), loquat, apricot, jujube, chestnut, matatabi (silvervine), and sumomo (Japanese plum); (c) a yeast- and/or lactic acid bacterium-fermented product of one or more kinds of root crops and/or potatoes selected from the group consisting of murasaki-imo (purple sweet potato), kikuimo (Jerusalem artichoke), carrot, onion, satsuma-imo (sweet potato), satoimo (taro), jinenzyo (Japanese yam), daikon (Japanese radish), akakabu (red turnip), gobo (burdock root), renkon (lotus root), yacon, yuri-ne (lily bulb), kuwai (arrowhead), ginger, garlic, and turmeric; (d) a yeast- and/or lactic acid bacterium-fermented product of one or more kinds of flowers and/or leaf vegetables selected from the group consisting of cabbage, shiso (perilla), mulberry leaves, dokudami (Korean houttuynia), yomogi (wormwood), kumazasa (kuma bamboo grass), and dandelion; (e) a yeast- and/or lactic acid bacterium-fermented product of one or more kinds of seaweeds selected from the group consisting of kombu (sea tangle), wakame (Undaria pinnatifida), and mozuku (Nemacystus decipiens); (f) a yeast- and/or lactic acid bacterium-fermented product of one or more kinds of seeds selected from the group consisting of black sesame seeds, walnuts, and ginkgo nuts; and (g) a yeast- and/or lactic acid bacterium-fermented product of one or two kinds of mushrooms selected from the group consisting of maitake (Grifola frondosa) and shiitake (Lentinus edodes).

公开(公告)号：US20170360701A2

公开(公告)日：2017-12-21

申请号：US15287346

申请日：2016-10-06

申请人： BRAINGEAR ENTERPRISES, INC.

发明人： Patricia Gutierrez ,  Christina Beer

IPC分类号： A61K9/00 ,  A61K31/355 ,  A61K31/455 ,  A61K31/4415 ,  A61K31/714 ,  A23L2/52 ,  A61K31/14 ,  A61K31/047 ,  A61K31/198 ,  A61K31/133 ,  A61K36/82 ,  A61K31/4745 ,  A61K31/593 ,  A61K31/225

CPC分类号： A61K9/0095 ,  A23L2/52 ,  A23L2/68 ,  A23L33/10 ,  A23L33/105 ,  A23L33/15 ,  A23V2002/00 ,  A61K31/047 ,  A61K31/13 ,  A61K31/133 ,  A61K31/14 ,  A61K31/194 ,  A61K31/198 ,  A61K31/225 ,  A61K31/355 ,  A61K31/385 ,  A61K31/4406 ,  A61K31/4415 ,  A61K31/455 ,  A61K31/473 ,  A61K31/4745 ,  A61K31/59 ,  A61K31/593 ,  A61K31/714 ,  A61K36/16 ,  A61K36/258 ,  A61K36/68 ,  A61K36/81 ,  A61K36/82 ,  A61K36/87 ,  A61K47/18 ,  A61K47/183 ,  A61K2300/00

摘要： Compositions that can be used to improve human health, and in particular brain health are provided. In some embodiments the composition comprises Inositol, N-Acetyl L-Tyrosine, pyrroloquinoline quinone (PQQ), Choline bitartrate, L-Theanine and Acetyl-L-Carnitine. The compositions may be administered to a subject, for example in the form of a liquid drink, to improve brain health.

公开(公告)号：US09844575B2

公开(公告)日：2017-12-19

申请号：US14759471

申请日：2014-01-10

申请人： KOREA INSTITUTE OF ORIENTAL MEDICINE

发明人： Jin Sook Kim ,  Jung Hyun Kim ,  Chan Sik Kim ,  Young Sook Kim ,  Eun Jin Shon ,  Yun Mi Lee ,  Dong Ho Jung ,  Ik Soo Lee ,  Gyu Hyeong Jo ,  Joo Hwan Kim

IPC分类号： A61K36/00 ,  A61K36/25 ,  A61K31/155 ,  A61K36/708 ,  A61K36/488 ,  A61K36/16 ,  A61K36/482 ,  A61K36/45 ,  A61K36/73 ,  A61K36/87 ,  A61K36/718 ,  A23L33/105

CPC分类号： A61K36/25 ,  A23L33/105 ,  A23V2002/00 ,  A61K31/155 ,  A61K36/16 ,  A61K36/45 ,  A61K36/482 ,  A61K36/488 ,  A61K36/708 ,  A61K36/718 ,  A61K36/73 ,  A61K36/87 ,  A61K2300/00

摘要： The present invention relates to a pharmaceutical composition and a health functional food composition for prevention, treatment or amelioration of diabetic complications or angioedema containing a mixed extract of Hedera helix leaves and Coptis chinensis as an active ingredient. More specifically, the present invention relates to a pharmaceutical composition and a health functional food composition for prevention, treatment or amelioration of diabetic complications or angioedema further containing an extract of Rheum palmatum, Puerariae radix, Ginkgo leaves, Cassiae semen, blueberry, bilberry, raspberry, or grape seeds as an active ingredient, in addition to the mixed extract of Hedera helix leaves and Coptis chinensis.

公开(公告)号：US20170325489A1

公开(公告)日：2017-11-16

申请号：US15156128

申请日：2016-05-16

申请人： Phytonutritia, LLC

发明人： Raed Omar

IPC分类号： A23L13/40 ,  A61K31/685 ,  A61K31/522 ,  A61K31/205 ,  A61K31/185 ,  A23L27/20 ,  A61K31/14 ,  A61K31/047 ,  A23L27/23 ,  A23L27/21 ,  A61K36/16 ,  A61K31/198

CPC分类号： A23L13/40 ,  A23L27/204 ,  A23L27/215 ,  A23L27/23 ,  A23L33/105 ,  A23L33/17 ,  A23V2002/00 ,  A61K31/047 ,  A61K31/14 ,  A61K31/185 ,  A61K31/198 ,  A61K31/205 ,  A61K31/522 ,  A61K31/685 ,  A61K36/16 ,  A61K2300/00 ,  A23V2200/322 ,  A23V2200/33 ,  A23V2250/2108 ,  A23V2250/304 ,  A23V2250/5432 ,  A23V2250/70

摘要： A gelatin based edible energy composition including at least a protein based gelatin, a methylated xanthine, and a choline derivative. Other embodiments may be described and claimed including compositions with at least a flavorant and a sweetener.

公开(公告)号：US09789119B2

公开(公告)日：2017-10-17

申请号：US14610976

申请日：2015-01-30

申请人： The Board of Trustees of the Leland Stanford Junior University

发明人： Craig C. Garner ,  H Craig Heller ,  Damien Colas ,  Daniel Z. Wetmore

IPC分类号： A61K31/55 ,  A61K31/365 ,  A61K36/16

CPC分类号： A61K31/55 ,  A61K31/365 ,  A61K36/16

摘要： Provided herein are methods, drug formulations, and dosing regimens for improving cognitive function in a normal or cognitively impaired subject. For instance, methods provided herein comprise administering a GABAA receptor antagonist so that peak concentration of the GABAA receptor antagonist occurs when the subject is asleep.